Anti-platelet and anti-coagulant therapy in peripheral arterial disease prior to surgical intervention.
CONCLUSION: Peripheral artery disease is a complex and multifactorial clinical condition. The use of dual anti-platelets, such as aspirin and clopidogrel, are the key in preventing major cardiovascular events as well as stroke and death. Utilization of anti-coagulation such as direct oral anti-coagulants' as additional parameters for the prevention of disease progression, is paramount. Eventually, the choice of either dual-antiplatelet therapy or combined anti-coagulation with anti-platelets should be carefully considered, particularly following the most recent published debatable studies.
PMID: 30539687 [PubMed - as supplied by publisher]
Source: Vascular - Category: Surgery Authors: Harky A, Maskell P, Burgess M Tags: Vascular Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Clopidogrel | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Peripheral Vascular Disease (PVD) | Plavix | Stroke | Study | Surgery